1. Home
  2. TAK vs FANG Comparison

TAK vs FANG Comparison

Compare TAK & FANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • FANG
  • Stock Information
  • Founded
  • TAK 1781
  • FANG 2007
  • Country
  • TAK Japan
  • FANG United States
  • Employees
  • TAK N/A
  • FANG N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • FANG Oil & Gas Production
  • Sector
  • TAK Health Care
  • FANG Energy
  • Exchange
  • TAK Nasdaq
  • FANG Nasdaq
  • Market Cap
  • TAK 47.3B
  • FANG 41.3B
  • IPO Year
  • TAK N/A
  • FANG 2012
  • Fundamental
  • Price
  • TAK $15.08
  • FANG $134.53
  • Analyst Decision
  • TAK
  • FANG Strong Buy
  • Analyst Count
  • TAK 0
  • FANG 22
  • Target Price
  • TAK N/A
  • FANG $192.52
  • AVG Volume (30 Days)
  • TAK 3.1M
  • FANG 1.7M
  • Earning Date
  • TAK 10-30-2025
  • FANG 11-03-2025
  • Dividend Yield
  • TAK 3.60%
  • FANG 4.04%
  • EPS Growth
  • TAK N/A
  • FANG N/A
  • EPS
  • TAK 0.59
  • FANG 14.15
  • Revenue
  • TAK $31,053,301,865.00
  • FANG $13,410,000,000.00
  • Revenue This Year
  • TAK $0.40
  • FANG $39.74
  • Revenue Next Year
  • TAK $0.83
  • FANG N/A
  • P/E Ratio
  • TAK $25.50
  • FANG $9.52
  • Revenue Growth
  • TAK 1.52
  • FANG 49.77
  • 52 Week Low
  • TAK $12.80
  • FANG $114.00
  • 52 Week High
  • TAK $15.69
  • FANG $200.47
  • Technical
  • Relative Strength Index (RSI)
  • TAK 50.98
  • FANG 38.02
  • Support Level
  • TAK $14.87
  • FANG $136.12
  • Resistance Level
  • TAK $15.38
  • FANG $140.20
  • Average True Range (ATR)
  • TAK 0.18
  • FANG 3.62
  • MACD
  • TAK -0.02
  • FANG -0.91
  • Stochastic Oscillator
  • TAK 32.97
  • FANG 1.45

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About FANG Diamondback Energy Inc.

Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2024, the company reported net proven reserves of 3.6 billion barrels of oil equivalent. Net production averaged about 598,000 barrels per day in 2024, at a ratio of 56% oil, 23% natural gas liquids, and 21% natural gas.

Share on Social Networks: